EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Microbiome analysis of bronchoalveolar lavage (BAL) specimens from immunocompromised patients with pneumonia compared to those from healthy volunteers

Zareen Fatima, Matthew D Surette, Sarah Marttala, Daniela Leto, Padman Jayaratne, Fiona Smaill, Marek Smieja, Mohammad Rubayet Hasan iD

PLOS One · 10.06.2026 · 21 (6) · e0351562

DOI: 10.1371/journal.pone.0351562 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift PLOS One, online erschienen am 10.06.2026. Verfasst von Zareen Fatima und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Canada. Hauptthemen laut MEDLINE: Immunocompromised Host, Bronchoalveolar Lavage Fluid, Microbiota, Pneumonia. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Metagenomic sequencing of bronchoalveolar lavage (BAL) specimens is increasingly being applied for the diagnosis of lower respiratory tract infections, offering agnostic pathogen detection and a faster turnaround time. While metagenomic sequencing of BAL specimens can reveal a wide range of organisms, their clinical relevance is often unclear because of the challenge of distinguishing true pathogens from background taxa. This study compared the BAL microbiomes of immunocompromised patients with pneumonia to those of healthy volunteers, with the aim of assisting clinical interpretation of metagenomics-based approaches for diagnosing pneumonia in this patient population.

Methods

BAL specimens from healthy control volunteers (n = 20) were collected during a COVID-19 vaccine trial, while residual BAL specimens from immunocompromised patients (n = 52) were obtained from the Hamilton Regional Laboratory Medicine Program (HRLMP) after standard culture and PCR testing. 16S rRNA gene amplicon sequencing was performed using Nanopore technology. Reads were classified using Minimap2 in EPI2ME, and microbiome analyses were conducted using the vegan and MaAsLin2 packages in RStudio (v2026.1.1.403).

Results

Immunocompromised patients showed significantly lower bacterial read counts and reduced alpha diversity (p < 0.0001; Wilcoxon Rank-Sum test), along with higher inter-sample heterogeneity. In contrast, BAL samples from healthy controls exhibited a more homogeneous microbial profile dominated by anaerobic Gram-negative genera, including Prevotella, Veillonella, Selenomonas , and Fusobacterium . Beta diversity analyses using Bray–Curtis and Jaccard distance metrics demonstrated significant compositional separation between cohorts (PERMANOVA p = 0.001), with tight clustering of healthy controls and marked dispersion among immunocompromised samples. Differential abundance analysis identified 96 significantly altered species (q < 0.05), with immunocompromised patients showing depletion of anaerobic commensals and enrichment of clinically relevant pathogens, including Stenotrophomonas maltophilia , Enterococcus spp., Mycoplasma spp., and Nocardia spp.

Conclusion

Immunocompromised patients demonstrated a markedly disrupted and heterogeneous BAL microbiome, characterized by a loss of anaerobic commensals and an enrichment of potentially pathogenic taxa. This study provides a characterization of the dysbiotic state in immunocompromised pneumonia, offering a baseline reference for future longitudinal studies and clinical trials aimed at improving the interpretation of metagenomic findings in this patient population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunocompromised HostBronchoalveolar Lavage FluidMicrobiotaPneumoniaHumansMaleFemaleMiddle AgedAdultRNA, Ribosomal, 16SAgedHealthy VolunteersMetagenomicsCase-Control StudiesBacteriaCOVID-19SARS-CoV-2

Substanzen

RNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Canada.
  • Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.
  • Research Institute of St. Joe's Hamilton, Hamilton, Canada.
  • Hamilton Regional Laboratory Medicine Program, Hamilton, Canada.

ORCID-Profile: Mohammad Rubayet Hasan

Zitieren

APA

Fatima, Z., Surette, M. D., Marttala, S., Leto, D., Jayaratne, P., Smaill, F., Smieja, M., & Hasan, M. R. (2026). Microbiome analysis of bronchoalveolar lavage (BAL) specimens from immunocompromised patients with pneumonia compared to those from healthy volunteers. PLOS One, 21(6), e0351562. https://doi.org/10.1371/journal.pone.0351562

Vancouver

Fatima Z, Surette MD, Marttala S, Leto D, Jayaratne P, Smaill F, et al. Microbiome analysis of bronchoalveolar lavage (BAL) specimens from immunocompromised patients with pneumonia compared to those from healthy volunteers. PLOS One. 2026;21(6):e0351562. doi:10.1371/journal.pone.0351562

BibTeX
@article{Fatima2026,
  author = {Fatima, Zareen and Surette, Matthew D and Marttala, Sarah and Leto, Daniela and Jayaratne, Padman and Smaill, Fiona and Smieja, Marek and Hasan, Mohammad Rubayet},
  title = {Microbiome analysis of bronchoalveolar lavage (BAL) specimens from immunocompromised patients with pneumonia compared to those from healthy volunteers},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {6},
  pages = {e0351562},
  doi = {10.1371/journal.pone.0351562}
}
Kostenlos starten →